Alexander Shulgin and the War on Drugs
This week’s death of Alexander “Sasha” Shulgin, the chemist in Berkeley who is credited with developing the party drug ecstasy, reminded us of a 2005 piece he wrote for MIT Technology Review (“Abused Substances”) in which he argued that the so-called war on drugs inhibited research into potentially beneficial psychedelic compounds. At the time, clinical trials were examining whether psychedelic drugs could be used to help people with obsessive-compulsive disorder, anxiety, or post-traumatic stress disorder, and Shulgin hoped that medical and legal winds would shift in favor of his kind of research.
That hasn’t really borne out. But read the piece anyway for a lesson on the difference between entactogens, empathogens, and entheogens.
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
ChatGPT is about to revolutionize the economy. We need to decide what that looks like.
New large language models will transform many jobs. Whether they will lead to widespread prosperity or not is up to us.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
GPT-4 is bigger and better than ChatGPT—but OpenAI won’t say why
We got a first look at the much-anticipated big new language model from OpenAI. But this time how it works is even more deeply under wraps.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.